Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

The prevention and regression of atherosclerotic plaques: emerging treatments.

Kalanuria AA, Nyquist P, Ling G.

Vasc Health Risk Manag. 2012;8:549-61. doi: 10.2147/VHRM.S27764. Epub 2012 Sep 25. Review.

PMID:
23049260
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

An emerging paradigm in atherosclerosis: focus on subclinical disease.

Miller M.

Postgrad Med. 2009 Mar;121(2):49-59. doi: 10.3810/pgm.2009.03.1976. Review.

PMID:
19332962
[PubMed - indexed for MEDLINE]
3.
4.

From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report.

Naghavi M, Falk E, Hecht HS, Jamieson MJ, Kaul S, Berman D, Fayad Z, Budoff MJ, Rumberger J, Naqvi TZ, Shaw LJ, Faergeman O, Cohn J, Bahr R, Koenig W, Demirovic J, Arking D, Herrera VL, Badimon J, Goldstein JA, Rudy Y, Airaksinen J, Schwartz RS, Riley WA, Mendes RA, Douglas P, Shah PK; SHAPE Task Force.

Am J Cardiol. 2006 Jul 17;98(2A):2H-15H. Epub 2006 Jun 12. Review.

PMID:
16843744
[PubMed - indexed for MEDLINE]
5.

From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.

Chapman MJ.

Pharmacol Ther. 2007 Jan;113(1):184-96. Epub 2006 Sep 15. Review.

PMID:
17070923
[PubMed - indexed for MEDLINE]
6.

[Exercise therapy for prevention of atherosclerosis].

Sasaki J.

Nihon Rinsho. 2011 Jan;69(1):119-24. Review. Japanese.

PMID:
21226271
[PubMed - indexed for MEDLINE]
7.

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.

Greenhalgh J, Bagust A, Boland A, Martin Saborido C, Oyee J, Blundell M, Dundar Y, Dickson R, Proudlove C, Fisher M.

Health Technol Assess. 2011 Sep;15(31):1-178. doi: 10.3310/hta15310. Review.

PMID:
21888837
[PubMed - indexed for MEDLINE]
Free Article
8.

Imaging of atherosclerosis: magnetic resonance imaging.

Corti R, Fuster V.

Eur Heart J. 2011 Jul;32(14):1709-19b. doi: 10.1093/eurheartj/ehr068. Epub 2011 Apr 19. Review.

PMID:
21508002
[PubMed - indexed for MEDLINE]
Free Article
9.

Is atherosclerosis regression a realistic goal of statin therapy and what does that mean?

Singh M, Bedi US.

Curr Atheroscler Rep. 2013 Jan;15(1):294. doi: 10.1007/s11883-012-0294-4. Review.

PMID:
23250630
[PubMed - indexed for MEDLINE]
10.

Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.

Kones R.

Drug Des Devel Ther. 2011;5:325-80. doi: 10.2147/DDDT.S14934. Epub 2011 Jun 13. Review.

PMID:
21792295
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Vulnerable plaque and inflammation: potential clinical strategies.

Drakopoulou M, Toutouzas K, Michelongona A, Tousoulis D, Stefanadis C.

Curr Pharm Des. 2011 Dec;17(37):4190-209. Review.

PMID:
22204378
[PubMed - indexed for MEDLINE]
12.

Antiplatelet drugs--do we need new options? With a reappraisal of direct thromboxane inhibitors.

Coccheri S.

Drugs. 2010 May 7;70(7):887-908. doi: 10.2165/11536000-000000000-00000. Review.

PMID:
20426498
[PubMed - indexed for MEDLINE]
13.

Role of platelet inhibitor therapy in myocardial infarction.

Stein B, Fuster V.

Cardiovasc Drugs Ther. 1989 Dec;3(6):797-813. Review.

PMID:
2487543
[PubMed - indexed for MEDLINE]
14.

Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus.

Otsuki M, Goya K, Kasayama S.

Vasc Health Risk Manag. 2005;1(3):209-15. Review.

PMID:
17319106
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

[Regression of atherosclerotic plaques during treatment with statins].

Kovárník T, Aschermann M.

Cas Lek Cesk. 2004;143(10):669-74; discussion 674-5. Review. Czech.

PMID:
15584615
[PubMed - indexed for MEDLINE]
16.

The burden of peripheral artery disease and the role of antiplatelet therapy.

Aronow H, Hiatt WR.

Postgrad Med. 2009 Jul;121(4):123-35. doi: 10.3810/pgm.2009.07.2038. Review.

PMID:
19641278
[PubMed - indexed for MEDLINE]
17.

Carotid artery disease and stroke in patients with peripheral arterial disease. The role of inflammation.

Sirico G, Spadera L, De Laurentis M, Brevetti G.

Monaldi Arch Chest Dis. 2009 Mar;72(1):10-7. Review.

PMID:
19645207
[PubMed - indexed for MEDLINE]
18.

Current imaging modalities for atherosclerosis.

Kataoka Y, Uno K, Puri R, Nicholls SJ.

Expert Rev Cardiovasc Ther. 2012 Apr;10(4):457-71. doi: 10.1586/erc.12.28. Review.

PMID:
22458579
[PubMed - indexed for MEDLINE]
19.

Treatment targets in the management of dyslipidemias: which targets in whom?

Grundy SM.

Curr Cardiol Rep. 2012 Dec;14(6):692-700. doi: 10.1007/s11886-012-0305-7.

PMID:
22956441
[PubMed - indexed for MEDLINE]
20.

The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.

Høgh AL.

Dan Med J. 2012 Sep;59(9):B4514. Review.

PMID:
22951205
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk